ArthroCare (ARTC) Catches Eye: Stock Up 14.8% – Tale of the Tape

ZacksArthroCare Corporation (ARTC) was a big mover last session, as its shares rose almost 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $38.10 to $40.58 in the past one-month time frame.

In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate hasn’t been in a trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

ArthroCare currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Some better-ranked medical stocks include CryoLife Inc. (CRY), Cepheid (CPHD) and Cyberonics Inc. (CYBX). While CryoLife and Cepheid sport a Zacks Rank #1 (Strong Buy), Cyberonics holds a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply